Heartflow Sues Cleerly Over Alleged Patent Infringement of Six AI Tools for Coronary Artery Disease Evaluation

Heartflow has filed a lawsuit against Cleerly, alleging that three of the Texas-based company’s artificial intelligence (AI)-based tools for coronary artery disease (CAD) evaluation infringe on six of its patents.

Filed on 13 April in the US District Court for the Eastern District of Texas, Heartflow’s complaint seeks “permanent injunctive relief and damages” arising from what the company claims is Cleerly’s “unauthorised and continued use” of Heartflow’s patented technology. 

Read more at MSN